These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9794371

  • 1. Chemotactic activity of soluble Fas ligand against phagocytes.
    Seino K, Iwabuchi K, Kayagaki N, Miyata R, Nagaoka I, Matsuzawa A, Fukao K, Yagita H, Okumura K.
    J Immunol; 1998 Nov 01; 161(9):4484-8. PubMed ID: 9794371
    [Abstract] [Full Text] [Related]

  • 2. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity.
    Shimizu M, Fontana A, Takeda Y, Yoshimoto T, Tsubura A, Matsuzawa A.
    Cell Immunol; 2001 Jan 10; 207(1):41-8. PubMed ID: 11161452
    [Abstract] [Full Text] [Related]

  • 3. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation.
    Dupont PJ, Warrens AN.
    Immunology; 2007 Jan 10; 120(1):133-9. PubMed ID: 17233740
    [Abstract] [Full Text] [Related]

  • 4. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model.
    Nagata S.
    J Hum Genet; 1998 Jan 10; 43(1):2-8. PubMed ID: 9609991
    [Abstract] [Full Text] [Related]

  • 5. The expression of genes modulating programmed cell death in normal human polymorphonuclear neutrophils.
    Hsieh SC, Huang MH, Tsai CY, Tsai YY, Tsai ST, Sun KH, Yu HS, Han SH, Yu CL.
    Biochem Biophys Res Commun; 1997 Apr 28; 233(3):700-6. PubMed ID: 9168918
    [Abstract] [Full Text] [Related]

  • 6. Neutrophil apoptosis in autoimmune Fas-defective MRL lpr/lpr mice.
    Giudice ED, Ciaramella A, Balestro N, Neumann D, Romano PG, Cesaroni MP, Maurizi G, Ruggiero P, Boraschi D, Bossù P.
    Eur Cytokine Netw; 2001 Apr 28; 12(3):510-7. PubMed ID: 11566632
    [Abstract] [Full Text] [Related]

  • 7. Human Fas-ligand expression on porcine endothelial cells does not protect against xenogeneic natural killer cytotoxicity.
    Matter-Reissmann UB, Sonntag KC, Gilli UO, Leguern C, Schneider MK, Seebach JD.
    Xenotransplantation; 2004 Jan 28; 11(1):43-52. PubMed ID: 14962292
    [Abstract] [Full Text] [Related]

  • 8. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
    Shimizu M, Fontana A, Takeda Y, Yagita H, Yoshimoto T, Matsuzawa A.
    J Immunol; 1999 Jun 15; 162(12):7350-7. PubMed ID: 10358186
    [Abstract] [Full Text] [Related]

  • 9. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y, Ramnath VR, Eaton AS, Chen A, Simon-Stoos KL, Kleiner DE, Erikson J, Puck JM.
    Clin Immunol; 1999 Oct 15; 93(1):34-45. PubMed ID: 10497009
    [Abstract] [Full Text] [Related]

  • 10. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W, Osaki T, Okamura H, Robbins PD, Kurimoto M, Nagata S, Lotze MT, Tahara H.
    J Immunol; 1999 Jul 15; 163(2):583-9. PubMed ID: 10395644
    [Abstract] [Full Text] [Related]

  • 11. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D, Savir A, Bhardwaj N, Elkon KB.
    J Immunol; 1999 Nov 15; 163(10):5303-11. PubMed ID: 10553053
    [Abstract] [Full Text] [Related]

  • 12. Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes.
    Ottonello L, Tortolina G, Amelotti M, Dallegri F.
    J Immunol; 1999 Mar 15; 162(6):3601-6. PubMed ID: 10092820
    [Abstract] [Full Text] [Related]

  • 13. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC, Murray SL, Balakrishnan VS, Guo D, King AJ, Pereira BJ, Jaber BL.
    J Lab Clin Med; 2000 Oct 15; 136(4):320-7. PubMed ID: 11039853
    [Abstract] [Full Text] [Related]

  • 14. Fas is expressed early in human thymocyte development but does not transmit an apoptotic signal.
    Jenkins M, Keir M, McCune JM.
    J Immunol; 1999 Aug 01; 163(3):1195-204. PubMed ID: 10415014
    [Abstract] [Full Text] [Related]

  • 15. Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera.
    Matsuno H, Yudoh K, Nakazawa F, Sawai T, Uzuki M, Nishioka K, Yonehara S, Nakayama J, Ohtsuki M, Kimura T.
    J Rheumatol; 2002 Aug 01; 29(8):1609-14. PubMed ID: 12180717
    [Abstract] [Full Text] [Related]

  • 16. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.
    Thomas HE, Darwiche R, Corbett JA, Kay TW.
    J Immunol; 1999 Aug 01; 163(3):1562-9. PubMed ID: 10415060
    [Abstract] [Full Text] [Related]

  • 17. Prominent dominant negative effect of a mutant Fas molecule lacking death domain on cell-mediated induction of apoptosis.
    Yokota A, Takeuchi E, Iizuka M, Ikegami Y, Takayama H, Shinohara N.
    Mol Immunol; 2005 Jan 01; 42(1):71-8. PubMed ID: 15488945
    [Abstract] [Full Text] [Related]

  • 18. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice.
    Jabs DA, Lee B, Whittum-Hudson J, Prendergast RA.
    Invest Ophthalmol Vis Sci; 2001 Feb 01; 42(2):399-401. PubMed ID: 11157873
    [Abstract] [Full Text] [Related]

  • 19. Antitumor effects are produced by forced expression of membrane-bound but not soluble Fas ligand in murine lung carcinoma cells.
    Tada Y, O-Wang J, Seimiya M, Takiguchi Y, Tatsumi K, Kuriyama T, Tagawa M.
    Anticancer Res; 2002 Feb 01; 22(2A):831-6. PubMed ID: 12014659
    [Abstract] [Full Text] [Related]

  • 20. Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis.
    Kim H, Whartenby KA, Georgantas RW, Wingard J, Civin CI.
    Stem Cells; 2002 Feb 01; 20(2):174-82. PubMed ID: 11897874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.